Acquisitions13 Nov 2025, 09:01 pm
Nectar Lifesciences Ltd Completes Slump Sale with Ceph Lifesciences for INR 1273.99 Crore
AI Summary
Nectar Lifesciences Ltd has completed a slump sale and assets transfer with Ceph Lifesciences Private Limited. The final consideration under the Business Transfer Agreement (BTA) is INR 1253.99 crore, adjusted for working capital. The final consideration under the Asset Purchase Agreement (APA) remains INR 20.00 crore as previously disclosed. This development was pursuant to Regulation 30 of the SEBI LODR Regulations and took place on November 10, 2025.
Key Highlights
- Nectar Lifesciences Ltd completes slump sale with Ceph Lifesciences Private Limited
- The final consideration under BTA is INR 1253.99 crore
- The final consideration under APA is INR 20.00 crore
- The sale was pursuant to Regulation 30 of the SEBI LODR Regulations
- The transaction was completed on November 10, 2025